Pools of cell lines carrying a variety of known mutations are used to validate the performance of a cancer diagnostic test based on next-generation sequencing.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Comparing the performance of selected variant callers using synthetic data and genome segmentation
BMC Bioinformatics Open Access 19 November 2018
-
ToTem: a tool for variant calling pipeline optimization
BMC Bioinformatics Open Access 26 June 2018
-
CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR
Oncogene Open Access 28 August 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Frampton, G.M. et al. Nat. Biotechnol. 31, 1023–1031 (2013).
Conti, R.M. et al. J. Clin. Oncol. 31, 1134–1139 (2013).
Gargis, A.S. et al. Nat. Biotechnol. 30, 1033–1036 (2012).
Rehm, H.L. et al. Genet. Med. 15, 733–747 (2013).
CAP Laboratory Accreditation Program. Molecular Pathology Checklist http://www.cap.org/apps/docs/laboratory_accreditation/checklists/new/molecular_pathology_checklist.pdf (College of American Pathologists, 2013).
Bose, R. et al. Cancer Discov. 3, 224–237 (2013).
Krzyzanowska, M.K. J. Clin. Oncol. 31, 1125–1127 (2013).
Alberts, S.R. et al. J. Am. Med. Assoc. 307, 1383–1393 (2012).
Garber, K. J. Natl. Cancer Inst. 103, 84–86 (2011).
Simon, R. & Roychowdhury, S. Nat. Rev. Drug Discov. 12, 358–369 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Park, J., Kricka, L. & Fortina, P. Next-generation sequencing in the clinic. Nat Biotechnol 31, 990–992 (2013). https://doi.org/10.1038/nbt.2743
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2743
This article is cited by
-
Comparing the performance of selected variant callers using synthetic data and genome segmentation
BMC Bioinformatics (2018)
-
ToTem: a tool for variant calling pipeline optimization
BMC Bioinformatics (2018)
-
CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR
Oncogene (2017)
-
Merkel Cell Carcinoma with a Suppressor of Fused (SUFU) Mutation: Case Report and Potential Therapeutic Implications
Dermatology and Therapy (2015)